Registered Botswana · BoMRA

STREPSILS COOLMINT LOZENGES

Amylmetacresol and 2,4-Dichlorobenzyl Alcohol 0.6 MG/1.2 MG

BOT1402335F LOZENGE 0.6 MG/1.2 MG dermatologicals INN generic

What it does

Alcohol is a substance that can affect your mood and behavior. It is important to use it carefully, especially if you are taking other medications.

Commonly used for: social enjoyment, anxiety relief, temporary relaxation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
BOT1402335F
Registration date
2014-01-29
Expiry date
2030-06-25
Status
Registered/Compliant
Active ingredient
Amylmetacresol and 2,4-Dichlorobenzyl Alcohol 0.6 MG/1.2 MG
Dosage form
LOZENGE
Strength
0.6 MG/1.2 MG
Pack size
-
Therapeutic class
-
ATC class (WHO)
D08AX - Other antiseptics and disinfectants
Drug group
DERMATOLOGICALS
RxNorm RxCUI
448
Country of origin
United Kingdom
Manufacturer location
Dansom Ln S, Hull HU8 7DS, UK

Source: Botswana Medicines Regulatory Authority · fetched 2026-09-18 04:32:31

Drug Interactions

8
Check interactions

Pharmacodynamic Warnings

Alcohol appears in TABLE 1: Drugs that cause hepatotoxicity

Alcohol appears in TABLE 8: Drugs that cause hypotension

Alcohol appears in TABLE 11: Drugs with CNS depressant effects

Unknown (8)

Acitretin - increases concentration

Alcohol potentially increases the concentration of retinoids (acitretin). Avoid and for 2 months after stopping acitretin.

Unknown Study

Antiepileptics - increases risk of visual disturbances

Alcohol potentially increases the risk of visual disturbances when given with antiepileptics (retigabine).

Unknown Study

Methylphenidate - increases concentration

Alcoholmightincreasetheconcentrationofmethylphenidate. Avoid.oStudy

Unknown Study

Retigabine - increases risk of visual disturbances

Alcohol potentially increases the risk of visual disturbances when given with antiepileptics (retigabine).

Unknown Study

Retinoids - increases concentration

Alcohol potentially increases the concentration of retinoids (acitretin). Avoid and for 2 months after stopping acitretin.

Unknown Study

Topical Pimecrolimus - increases risk of facial flushing and skin irritation

Alcohol increases the risk of facial flushing and skin irritation when given with topical pimecrolimus.

Unknown Study

Topical Tacrolimus - increases risk of facial flushing and skin irritation

Alcohol increases the risk of facial flushing and skin irritation when given with topical tacrolimus.

Unknown Study

Vasopressin - decreases antidiuretic effect

Alcoholmightdecreasetheantidiureticeffectofvasopressin. oTheoretical Aldesleukin →seeTABLE15p.1520(myelosuppression) Alectinib →seeTABLE6p.1518(bradycardia),TABLE1p.1517 (hepatotoxicity) com/codemedic

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: exact

Disclaimer: This information is sourced from Botswana Medicines Regulatory Authority (Botswana). Always consult a qualified healthcare professional before using any medication.

About alcohol

Alcohol is a substance that can affect your mood and behavior. It is important to use it carefully, especially if you are taking other medications.

What it treats

  • social enjoyment
  • anxiety relief
  • temporary relaxation

How it works

Alcohol affects the brain and central nervous system, leading to changes in mood and behavior.

Who it's for

Adults who consume alcohol in moderation for social or relaxation purposes.

Cautions

  • • Be cautious if taking medications that can harm the liver.
  • • Use with care if you have low blood pressure.
  • • Avoid combining with medications that can cause drowsiness.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About amylmetacresol

Amylmetacresol is a medication primarily used to soothe sore throats.

What it treats

  • sore throat
  • pharyngitis

How it works

It works by numbing the throat area to relieve pain and discomfort.

Who it's for

This medication is suitable for adults and children who are experiencing a sore throat.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Alcohol

BNF-referenced

Alcohol is a volatile, flammable liquid used primarily as an antiseptic for skin disinfection and preparation before injections. It is commonly employed in medical settings to cleanse the skin and reduce the risk of infection.

Indications

  • Skin disinfection
  • Preparation of skin before injections
  • Cleansing minor wounds

Dosage

Children: Apply to the skin as required; consult product literature for specific guidance.

Adults: Apply to the skin as required for disinfection.

Mechanism of action

Alcohol exerts its antiseptic effect by denaturing proteins, disrupting cell membranes, and dehydrating microbial cells, leading to cell lysis and death.

Pharmacodynamics

Alcohol has broad-spectrum antimicrobial activity, effective against bacteria, fungi, and viruses. Its efficacy is influenced by concentration, with higher concentrations generally being more effective.

Pharmacokinetics

Alcohol is rapidly absorbed through the skin and mucous membranes. It is metabolized primarily in the liver, with a half-life that varies based on the individual's metabolic rate and the amount consumed.

Contra-indications

  • Concomitant use with lithium
  • Regular use in neonates
  • Patients with severe burns when diathermy has been preceded by application of alcoholic skin disinfectants

Adverse effects

  • Eye erythema
  • Punctate keratitis
  • Cytotoxicity
  • Eye discolouration

Interactions

  • Increases risk of visual disturbances with antiepileptics
  • Increases concentration with methylphenidate
  • Increases risk of facial flushing and skin irritation with topical pimecrolimus
  • Increases concentration with retinoids
  • Increases concentration with acitretin
  • Increases risk of facial flushing and skin irritation with topical tacrolimus
  • Decreases antidiuretic effect with vasopressin

Precautions

  • Avoid regular application to inflamed or broken skin or mucosa
  • Avoid broken skin
  • Flammable

Pregnancy

Sufficient iodine may be absorbed to affect the fetal thyroid in the second and third trimester.

Breast-feeding

Avoid regular or excessive use.

Storage

Store in a cool, dry place away from heat and direct sunlight.

Formulations

  • Betadine 2.5% dry powder spray
  • Industrial methylated spirit
  • Povidone-Iodine 25 mg per 1 gram
BNF for Children 2019-2020 p.806 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: amylmetacresol

BNF-referenced

Amylmetacresol is an antiseptic agent with antibacterial and antiviral properties, commonly used in throat lozenges to alleviate sore throat symptoms. It is known for its virucidal action, which helps reduce the infectivity of viruses in the throat and cough droplets, thereby minimizing the risk of transmission.

Indications

  • Sore throat
  • Throat irritation
  • Symptomatic relief of throat infections

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidance.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

The mechanism of virucidal action is not fully elucidated; however, it is suggested that denaturation of external protein spikes, a pH-induced rearrangement of the tertiary structure of attachment proteins, or a selective effect on viral lipid membranes and protein-lipid interaction is responsible for this action. Amylmetacresol also blocks voltage-gated Na channels in a local anesthetic-like manner.

Pharmacodynamics

Amylmetacresol throat lozenges markedly reduce the infectivity of certain infectious viruses in the throat and in cough droplets, thus reducing opportunities for person-to-person transmission. Additionally, it relieves symptoms of sore throat and irritation of the throat by inhibiting the inflammatory and pain mediators involved in the inflammation of the mouth and throat mucous membranes.

Adverse effects

  • Allergic reactions
  • Local irritation
  • Nausea
  • Vomiting

Precautions

  • Use with caution in individuals with known allergies to local anesthetics.
  • Not recommended for prolonged use.

Pregnancy

Safety in pregnancy has not been established, consult healthcare provider before use.

Breast-feeding

Consult healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

  • Throat lozenges containing amylmetacresol

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Alcohol

PubChem CID 702

Molecular formula: C2H6O

Mechanism of action

Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes. ... Ethanol is known to affect a large number of membrane proteins that participate in signaling pathways such as neurotransmitter receptors, enzymes, and ion channels, and there is extensive evidence that ethanol interacts with a variety of neurotransmitters. The major actions of ethanol involve enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABAa receptors and blockade of the N-methyl-D-aspartate (NMDA) subtype of glutamate, an excitatory amine acid (EAA) receptor. Animal studies indicate that the acute effects of ethanol result from competitive inhibition of glycine binding to NMDA receptor and disruption of glutamatergic neurotransmission by inhibiting the response of the NMDA receptor. Persistent glycine antagonism and attenuation of glutamatergic neurotransmission by chronic ethanol exposure results in tolerance to ethanol by enhancing EAA neurotransmission and NMDA receptor upregulation. The latter appears to involve selective increases in NMDA R2B subunit concentrations and other molecular changes in specific brain loci. The abrupt withdrawal of ethanol thus produces a hyperexcitable state that leads to the ethanol withdrawal syndrome and excitotoxic neuronal death. GABA-mediated inhibition, which normally acts to limit excitation, is eliminated during ethanol withdrawal syndrome and further intensifies this excitation. In addition, NMDA receptors function to inhibit the release of dopamine in the nucleus accumbens and mesolimbic structures, which modulate the reinforcing action of addictive xenobiotics such as ethanol. By inhibiting NMDA receptor activity, ethanol could increase dopamine release from the nucleus accumbens and ventral tegmental area and could thus create dependence. Chronic ethanol administration also results in tolerance, dependence, and an ethanol withdrawal syndrome, mediated, in part, by desensitization and or downregulation of GABAa receptors. The development of alcoholic ketoacidosis (AKA) requires that a combination of physical and physiologic events occur. The normal response to starvation and depletion of hepatic glycogen stores is for amino acids to be converted to pyruvate. Pyruvate can serve as a substrate for gluconeogenesis, be converted to acetyl-CoA, which can enter the Krebs cycle or can be utilized in various biosynthetic pathways (eg, fatty acid, ketone bodies, cholesterol, and acetylcholine) ... Ethanol metabolism generates NADH, resulting in an excess of reducing potential. This high redox state favors the conversion of pyruvate to lactate, diverting pyruvate from being a substrate for gluconeogenesis. To compensate for the lack of normal metabolic substrates, the body mobilizes fat from adipose tissue and increased fatty acid metabolism as an alternative source of energy. This response is mediated by a decrease in insulin and an increased secretion of glucagon, catecholamines, growth hormone, and cortisol. Fatty acid metabolism results in the formation of acetyl-CoA and it combines with the excess acetate that is generated from ethanol metabolism to form acetoacetate. Most of the acetoacetate is reduced to beta-hydroxybutyrate due to the excess reducing potential or high redox state of the cell. Volume depletion interferes with the renal elimination of acetoacetate and beta-hydroxybutyrate, and contributes to the acidosis. An elevated lactate concentration may result from shunting from pyruvate or

Pharmacodynamics

Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol also binds to GABA, glycine, NMDA receptors and modulates their effects. Ethanol is also metabolised by the hepatic enzyme alcohol dehydrogenase.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: amylmetacresol

PubChem CID 14759

Molecular formula: C12H18O

Mechanism of action

The mechanism of virucidal action is not fully elucidated, however it is suggested that denaturation of external protein spikes, a pH-induced rearrangement of the tertiary structure of attachment proteins, or a selective effect on viral lipid membranes/protein–lipid interaction is responsible for this action. Amylmetacresol is an antibacterial and antiviral agent, and blocks voltage-gated Na channels in a local anesthetic-like manner.

Pharmacodynamics

The mixture of amylmetacresol throat lozenge medications markedly reduces the infectivity of certain infectious viruses in the throat and in cough droplets, thus reducing opportunities for person-to-person transmission. In addition, it relieves symptoms of sore throat/irritation of the throat,. Amylmetacresol is thought to inhibit the inflammatory and pain mediators that are involved in the inflammation of the mouth and throat mucous membranes, as well as the sore throat.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.